Trianni and LakePharma Announce Strategic Technology Partnering Agreement
SAN FRANCISCO & BELMONT, Calif.--(BUSINESS WIRE)--Trianni, Inc., (TRIANNI) a private biotech company developing novel antibody discovery platforms, and LakePharma, Inc., the leading contract research organization (CRO) offering integrated solutions for biologics discovery and development, today announced a technology partnership to empower antibody drug development. The agreement grants LakePharma the right to utilize the Trianni Mouse Platform for antibody discovery services. LakePharma will be responsible for marketing the Trianni Platform as part of its service offerings in the US. Financial terms were not disclosed.
The Trianni Mouse Platform enables the expression of antibodies with fully human variable domains, leveraging in vivo selection to increase antibody diversity and quality.
“TRIANNI is excited to enter into this alliance with LakePharma,” said Matthias Wabl, Ph.D., Chairman and CEO of TRIANNI. “We believe that the Trianni Platform, coupled with LakePharma’s robust antibody discovery and development service capabilities, will be an invaluable asset to clients seeking to develop antibody therapeutics.”
Hua Tu, Ph.D., Chairman and CEO of LakePharma added: “Bringing the Trianni Transgenic Mouse Platform in-house allows us to combine a world-class, novel technology with LakePharma’s unique immunization platform and screening strategies. We provide our clients with an unprecedented ability to conduct in vivo discovery of human monoclonal therapeutics in a proven combination of quality platforms.”
About Trianni, Inc.
TRIANNI is a privately held organization, formed in 2010 with a mission to use recent advances in DNA synthesis and genomic modification technology for the development of an optimized therapeutic antibody discovery platform, The Trianni Mouse. The company has research and administrative facilities in the San Francisco Bay Area (CA, USA) and in Research Triangle Park (NC, USA). For more information, please visit www.trianni.com.
About LakePharma, Inc.
LakePharma is a contract research organization (CRO) dedicated to serving the discovery research and development needs of companies engaged in the preclinical development of biotherapeutics. The company has assembled the United States’ most comprehensive set of technologies and expertise to offer a large continuum of services for antibody and protein discovery and engineering, cell line creation, and protein analytics. Clients may access our services individually or as a fully integrated “soup to nuts” solution for all of their molecular biology, protein chemistry, cell line, assay, and scale-up needs. For more information, please visit www.lakepharma.com.
Mandy Boyd, 1-415-231-0256 [o] 1-866-674-9314
Director of Marketing
Norm Garceau Ph.D.
VP of Technology